Fluticasone for Young Children
The FDA has approved drug fluticasone propionate (Flovent generic, GlaxoSmithKline) in asthmatic children 4 to 11 years of age. This inhaled corticosteroid helps prevent inflammation in the airways, one of the main components of asthma.
Flovent HFA, a reformulation of Flovent Inhalation Aerosol, uses hydro-fluoroalkane (HFA-134a) to propel the medication out of the canister and into the lungs. Hydrofluoroalkane replaces the chlorofluorocarbon propellant and is a more environmentally friendly aerosol formulation.
Flovent HFA was first approved in May 2004 for patients 12 years of age and older. The dosage for children 4 to 11 years of age is 88 mcg twice daily.





